Taken together, these observations suggest that ADAR1 helps cancer cells to suppress the inflammatory response driven by TE activation, thereby avoiding immunosurveillance or reduced fitness that could be driven by translational changes linked to IFN-induced RNAse L and PKR activities (Lamers et al., 2019). The gene discussed is ADAR; the disease is cancer.